Related Experiment Video
Updated: May 20, 2026
07:15
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Podocyte ACE2 protects against diabetic nephropathy
1Department of Veterans Affairs, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA. ray.harris@vanderbilt.edu
Kidney International
|July 14, 2012
Summary
Increased podocyte angiotensin-converting enzyme 2 (ACE2) activity helps prevent diabetic nephropathy development. This finding highlights ACE2
Area of Science:
- Renal physiology and pathophysiology
- Molecular mechanisms of kidney disease
- Endocrinology and metabolic disorders
Background:
- The kidney's intrinsic renin-angiotensin system (RAS) plays a crucial role in regulating renal function.
- Podocytes, specialized kidney cells, have a local RAS capable of producing angiotensin II.
- Angiotensin-converting enzyme 2 (ACE2) metabolizes angiotensin II, generating angiotensin-(1-7) and potentially mitigating RAS overactivity.
Purpose of the Study:
- To investigate the role of podocyte-specific angiotensin-converting enzyme 2 (ACE2) in the context of diabetic nephropathy.
- To determine if enhanced podocyte ACE2 activity can influence the progression of kidney damage in diabetes.
Main Methods:
- Utilized experimental models to assess podocyte ACE2 activity.
- Evaluated the impact of modulating podocyte ACE2 on markers of diabetic nephropathy.
Main Results:
- Demonstrated a functional link between podocyte ACE2 activity and the development of diabetic nephropathy.
- Showed that increased podocyte ACE2 activity significantly attenuated the progression of kidney disease in a diabetic setting.
Conclusions:
- Podocyte ACE2 is a key protective factor against the development of diabetic nephropathy.
- Targeting or enhancing podocyte ACE2 activity represents a potential therapeutic strategy for diabetic kidney disease.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...